TP53 and bladder transitional cell carcinoma: Intriguingly, another immunosuppressive cluster of CD47+PD-1+ cells showed strong interactions with Tregs in the low TP53 score group (Chen et al., 2021), further confirming the hypothesis that an immunosuppressive TME exists in patients with BLCA with a low TP53 score.